% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Yogeshwar:285470,
      author       = {Yogeshwar, Selina M and Bartels, Frederik and Grüter,
                      Thomas and Muñiz-Castrillo, Sergio and Picard, Géraldine
                      and Crijnen, Yvette S and Bernard, Emilien and Heidbreder,
                      Anna and Zekeridou, Anastasia and Ringelstein, Marius and
                      Kraft, Andrea and Kovac, Stjepana and Wandinger, Klaus-Peter
                      and de Vries, Juna M and Boon, Agnita J W and Veenbergen,
                      Sharon and Geis, Christian and Penner, Loana and Melzer,
                      Nico and Leypoldt, Frank and Blaabjerg, Morten and Pittock,
                      Sean J and Gaig, Carles and Sabater, Lidia and Santamaria,
                      Joan and Graus, Francesc and Dalmau, Josep and Prüss,
                      Harald and Höftberger, Romana and Schreiner, Bettina and
                      McKeon, Andrew and Lewerenz, Jan and Irani, Sarosh and
                      Mignot, Emmanuel and Titulaer, Maarten J and Ayzenberg, Ilya
                      and Honnorat, Jérôme and Finke, Carsten},
      collaboration = {Consortium, IgLON5 Imaging},
      othercontributors = {Francillard, Aurélie Méneret Isabelle and Renard, Dimitri
                          and Desestret, Virginie and Capet, Nicolas and Davion,
                          Jeanbaptiste and Boucher, Julie and Zephir, Helene and
                          Damier, Philippe and Combres, Helene and Rafiq, Marie and
                          Bonneville, Fabrice and Cumin, Marina and Soulages, Antoine
                          and Compoint, Mathilde and Moulin, Maximilien and Berling,
                          Edouard and Garrigues, Eve and Chanson, Marine and Bourg,
                          Veronique and Giordana, Caroline and Benoit, Jeanne and
                          Flabeau, Olivier and Derivoyre, Emmanuelle and Ryckewaert,
                          Gilles and Alberto, Tifanie and Carriere, Nicolas and
                          Mostoufizadehs, Sohrab and Barbay, Melanie and Benaiteau,
                          Marie and Vogrig, Alberto and Sellal, Francois and Casez,
                          Olivier and Bruel, Cedric and Kalifa, L. and Rusu, Elena
                          Camelia and Demortiere, Sarah and Maarouf, Adil and Wang,
                          Adrien and Brasset, Adelaide and Dalliere, Clarisse Carra
                          and Attal, Arthur and Demourant, Céline and Cluse, Florent
                          and Houeto, Jean-Luc and Brueggemann, Norbert and
                          Dargvainiene, Justina and Seifert, Thomas and Oy, Ulrich
                          Hofstadt-van and Nagel, Michael and Urbanek, Christian and
                          Schroeder, Ina and Schramm, Peter and Tonner, Silke and
                          Seitz, Caspar and Tschernatsch, Marlene and Chung, Ha-Yeun
                          and Wickel, Jonathan and Schoeberl, Florian and Macher,
                          Stefan and Simabukuro, Mateus M and Zittel-Dirks, Simone and
                          Wildemann, Brigitte and Kothaj, Jan and Ordas, Carlos and
                          Álvarez, Javier Villacieros and Angstwurm, Klemens and
                          Macher, Stefan and Berger-Sieczkowski, Evelyn and Tomás,
                          Ángela Milán and Bastida, Antonio Martin and Quintas,
                          Sonia and Tambasco, Nicola and Nigro, Pasquale and Iorio,
                          Raffaele and Ono, Yoya and Shimohata, Takayoshi and Akio,
                          Kimura and Akira, Takekoshi and Scheller-Nissen, Mette and
                          Hartmann, Christian and Bastiaansen, Danielle and van
                          Steenhoven, Robin and Schwichtenberg, Katia},
      title        = {{B}rain atrophy patterns in anti-{I}g{LON}5 disease.},
      journal      = {Brain},
      volume       = {149},
      number       = {3},
      issn         = {0006-8950},
      address      = {Oxford},
      publisher    = {Oxford Univ. Press},
      reportid     = {DZNE-2026-00247},
      pages        = {884 - 896},
      year         = {2026},
      abstract     = {Anti-IgLON5 disease is an autoimmune encephalitis that
                      presents with a heterogenous clinical phenotype, including
                      sleep disorders, movement abnormalities and bulbar
                      involvement. It is characterized by autoantibodies against
                      IgLON5, $85\%$ association with HLA-DQB1*05:∼ and a
                      brainstem-dominant tauopathy. Cellular and murine models
                      report pathogenic effects of the autoantibodies, and
                      neurodegenerative factors suggest progressive atrophy as a
                      common sequela. However, evidence from in vivo patient data
                      and long-term follow-up is limited, and the degree of
                      progression remains elusive. In this multicentre study,
                      clinical and brain MRI data were collected from 127 patients
                      across 12 countries to investigate the relationships between
                      clinical presentations and the development of distinct brain
                      atrophy patterns. Our data show that most patients develop a
                      complex multisystem phenotype as the disease progresses;
                      however, neuromuscular manifestations rarely emerge at later
                      disease stages. By comparison to healthy controls, this
                      disease presents with severe substructure-specific atrophy,
                      especially affecting the hypothalamus, brainstem, accumbens
                      and basal ganglia, which, in age-independent analyses, show
                      significant ventricular enlargement and also suggest
                      progression of brainstem atrophy over the disease course.
                      Moreover, the focality of atrophy was functionally linked to
                      specific symptoms, with more severe involvement of the basal
                      ganglia in patients with movement disorders, and greater
                      atrophy in the hippocampus and thalamus in patients with
                      cognitive impairment. Taken together, our results provide
                      evidence of distinct atrophy patterns in anti-IgLON5
                      disease, which closely mirror sites of pathophysiologic
                      processes, including autoantibody binding and tau
                      deposition. Our data emphasize the brainstem as the
                      pathophysiological hub of the disease and provide normative
                      data for the incorporation of atrophy measurements into
                      routine clinical assessments and future treatment studies to
                      monitor disease trajectory and evaluate future treatment
                      strategies.},
      keywords     = {Humans / Male / Atrophy: pathology / Female / Middle Aged /
                      Brain: pathology / Brain: diagnostic imaging / Aged /
                      Magnetic Resonance Imaging / Adult / Autoantibodies:
                      immunology / Cell Adhesion Molecules, Neuronal: immunology /
                      Disease Progression / Autoimmune Diseases of the Nervous
                      System: pathology / Autoimmune Diseases of the Nervous
                      System: diagnostic imaging / Autoimmune Diseases of the
                      Nervous System: immunology / Encephalitis: pathology /
                      Encephalitis: immunology / Encephalitis: diagnostic imaging
                      / IgLON5 (Other) / MRI (Other) / atrophy (Other) /
                      autoimmune encephalitis (Other) / IgLON5 protein, human (NLM
                      Chemicals) / Autoantibodies (NLM Chemicals) / Cell Adhesion
                      Molecules, Neuronal (NLM Chemicals)},
      cin          = {AG Prüß},
      ddc          = {610},
      cid          = {I:(DE-2719)1810003},
      pnm          = {353 - Clinical and Health Care Research (POF4-353)},
      pid          = {G:(DE-HGF)POF4-353},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:40650880},
      doi          = {10.1093/brain/awaf256},
      url          = {https://pub.dzne.de/record/285470},
}